---
title: 'SVP, Regulatory Affairs at Vir Biotechnology'
canonical: 'https://feeny.ai/job/svp-regulatory-affairs-vir-biotechnology-san-francisco-q3eswvctgp3v'
type: 'job'
last_seen: '2026-10-17'
---

# SVP, Regulatory Affairs at Vir Biotechnology

- **Company:** Vir Biotechnology
- **Location:** San Francisco, CA
- **Posted:** 2026-10-14
- **Last confirmed live:** 2026-10-17
- **Apply:** https://job-boards.greenhouse.io/virbiotechnologyinc/jobs/4743429005

## Job description

Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple PRO-XTEN® dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies.

Vir Biotechnology has exclusive rights to the universal PRO-XTEN® masking platform for oncology and infectious disease. PRO-XTEN® is a trademark of Amunix Pharmaceuticals, Inc., a Sanofi company.

We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best.

## THE OPPORTUNITY

Vir Biotechnology is seeking a strategic and experienced leader to serve as Senior Vice President, Regulatory Affairs. Based in San Francisco and reporting to the Chief Medical Officer, this individual will lead Vir Bio’s global Regulatory Affairs organization. This leader will be responsible for shaping and executing regulatory strategy across the portfolio, spanning preclinical development through approval and lifecycle management. The role will also provide immediate leadership and continuity for Vir Bio’s late-stage HDV program through filing readiness, submission, Health Authority review, and potential approval. As a key member of the Development Leadership Team, the SVP will partner across the organization to advance development programs, inform portfolio decisions, and help bring innovative medicines to patients worldwide.

The ideal candidate is an accomplished regulatory executive with deep experience leading global regulatory strategy across the full product development lifecycle, including significant Health Authority interactions, BLA submissions, biologics development, and major regulatory approvals. This leader has a proven track record of building high-performing teams, influencing key business and development decisions, and successfully navigating complex regulatory challenges within a dynamic biotechnology environment.

This role is located in our San Francisco headquarters with an expectation of at least 3 days per week in office.

## WHAT YOU'LL DO

- Lead and evolve Vir Bio's global Regulatory Affairs organization, setting the vision, strategy, structure, and capabilities needed to support the company's current and future portfolio
- Serve as the company's most senior regulatory leader, providing strategic counsel to executive leadership and influencing key portfolio, development, and business decisions
- Define and execute global regulatory strategies across all stages of development, balancing the immediate needs of a late-stage registration program as well as the differentiated regulatory pathways required for innovative early-stage programs.
- Lead and oversee regulatory interactions with global Health Authorities, building productive relationships, shaping regulatory pathways, and driving successful outcomes across key markets
- Lead filing readiness, cross-functional submission planning and execution, Health Authority review, approval activities, and post-marketing commitments for major regulatory applications, ensuring continuity, clear accountability, and alignment with corporate objectives and development priorities
- Assess regulatory risks, opportunities, and emerging trends to inform development strategy, portfolio decisions, and long-term business planning
- Partner across the organization to ensure regulatory considerations are integrated into development plans, portfolio strategy, and corporate objectives
- Build, develop, and retain a high-performing Regulatory Affairs organization while fostering a culture of collaboration, accountability, innovation, and continuous development
- Represent Regulatory Affairs on executive governance, portfolio review, and development leadership forums, serving as a trusted advisor and strategic thought partner to senior leadership
- Drive operational excellence across the regulatory function, ensuring effective planning, prioritization, resource allocation, and execution in support of company objectives
- Champion Vir Bio’s external presence within the regulatory and biotechnology communities through engagement with Health Authorities, industry organizations, professional societies, and key external stakeholders

## WHO YOU ARE AND WHAT YOU BRING

A highly experienced, strategic, and collaborative regulatory leader will thrive in this role. The successful candidate will bring deep expertise across the full product development lifecycle, a proven track record of shaping regulatory strategy for innovative therapies, and experience building and leading high-performing teams. Equally important, you are an influential leader who can navigate complexity, drive cross-functional alignment, and translate regulatory strategy into successful business and development outcomes.

- Advanced scientific or medical degree (PhD, PharmD, MD, or equivalent) preferred
- 15+ years of Regulatory Affairs experience with a proven track record of leadership and organizational impact across the biotechnology and/or pharmaceutical industry
- Extensive experience developing and executing global regulatory strategies across all stages of development, from preclinical development through approval and lifecycle management
- Proven track record of leading major regulatory submissions and approvals, including direct experience with BLA submissions, biologics development, and global registration strategies
- Significant experience leading regulatory interactions with FDA, EMA, and other global Health Authorities
- Demonstrated ability to influence executive-level decisions, balance risk, and guide complex development programs
- Experience building, developing, and leading high-performing global teams and organizations
- Exceptional communication, relationship-building, and stakeholder management skills

## #LI-AS1

#LI-Onsite

## WHO WE ARE AND WHAT WE OFFER

The expected salary range for this position is $350,000 to $400,000 per year. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors.

Vir Biotechnology's compensation and benefits are aligned with the current market and commensurate with the person’s experience and qualifications. All full-time employees receive a package that includes compensation, bonus and equity as well as many other Vir Biotechnology benefits and perks such as health and welfare benefit plans, non-accrual paid time off, company shut down for holidays, commuter benefits, 401K match and lunch each day in the office.

Applicants must currently be authorized to work for any employer in the U.S.  We are unable to sponsor or take over sponsorship of an employment Visa at this time.

All employment decisions at Vir Biotechnology are based on legitimate, non-discriminatory business requirements, job duties and individual qualifications. Employment decisions are made without regard to any legally protected characteristics.

This commitment extends to all management practices and decisions, including recruitment and hiring, compensation, appraisal systems, promotions, training and career development programs.  Vir Biotechnology also strongly commits to providing employees with a work environment free of unlawful conduct or harassment.

Vir Biotechnology Human Resources leads recruitment and employment for Vir Biotechnology. Unsolicited resumes sent to the company from recruiters do not constitute any type of relationship between the recruiter and Vir Biotechnology and do not obligate us to pay fees should we hire from those resumes. We ask that external recruiters and/or agencies not contact or present candidates directly to our hiring manager or employees.

For hires based in the United States, Vir Biotechnology, participates in [E-Verify](https://www.e-verify.gov/sites/default/files/everify/posters/EVerifyParticipationPoster.pdf).

[Candidate Privacy Notice](https://www.vir.bio/candidate-notice/)

## About Vir Biotechnology

## Company Overview
- **One-liner**: Vir Biotechnology is a clinical-stage immunology company focused on engineering powerful antibody-based medicines to treat infectious diseases and cancer.
- **Entity Type**: Public (Ticker: VIR)
- **Headquarters**: San Francisco, California, United States
- **Founded**: 2016
- **Founders**: Not publicly available (the company was formed with founding investments from ARCH Venture Partners, the Bill & Melinda Gates Foundation, and others)

## Core Business
- **Primary Industry**: Biotechnology (Immunology, Infectious Disease, Oncology)
- **Target Customers**: Patients with serious infectious diseases (e.g., chronic hepatitis delta, COVID-19, Ebola) and specific cancers; the company's customers are effectively patients and healthcare systems, with revenue coming from partnerships and product sales.
- **Mission/Purpose**: "Power the immune system to transform lives" by delivering potentially transformative medicines for patients with high unmet medical needs.

## Products & Services
- **Next-Generation Antibody Platform**: A proprietary platform that enables the rapid discovery, optimization, and advancement of antibody candidates for infectious diseases.
- **PRO-XTEN® Protease-Releasable Masking Technology**: A platform (exclusive rights for oncology and infectious disease) used to engineer conditionally activated antibodies that are designed to be safer and more effective in treating cancer. PRO-XTEN® is a trademark of Amunix Pharmaceuticals, Inc., a Sanofi company.
- **Pipeline Programs**: The company’s pipeline includes leading programs in chronic hepatitis delta virus (HDV) and strategically expanding into oncology. They have demonstrated their ability to discover and develop antibody-based medicines for COVID-19 and Ebola.

## Market Standing
- **Valuation/Market Cap**: Market cap fluctuates with stock price. As of recent reporting, it is in the range of several billion USD. For the most current figure, refer to financial data providers.
- **Key Metric**: As a public company, key metrics include R&D spending, cash position, and pipeline progress. The company had significant revenue from its COVID-19 antibody partnership (sotrovimab) but is now focused on advancing its pipeline.
- **Notable Investors/Partners**: Founding investors include ARCH Venture Partners and the Bill & Melinda Gates Foundation. Key partners include Alnylam Pharmaceuticals and Sanofi (via the Amunix/PRO-XTEN platform).
- **Growth Signals**: The company is actively expanding its oncology pipeline, appointing an SVP of Oncology and a Vice President of Clinical Research-Oncology. It continues to hire across R&D, regulatory, and business development, signaling a phase of growth and pipeline advancement.

## Competitive Advantages
- **Deep Immunology Expertise**: The company has a world-class team with deep knowledge of immunology and antibody engineering.
- **Dual-Platform Strategy**: Combining a powerful antibody discovery platform with the PRO-XTEN® masking technology gives it a unique ability to create both potent and safer therapies.
- **Proven Track Record**: Successfully developed and brought to market a COVID-19 antibody (sotrovimab) and an Ebola treatment (mAb114) on an accelerated timeline, demonstrating execution capability.
- **Focus on Unmet Needs**: Concentrates on diseases with limited treatment options, such as chronic hepatitis delta and hard-to-treat cancers.

## Strategic Focus
- **Infectious Disease Foundation**: Continuing to advance its core programs in infectious diseases, with a leading program in chronic hepatitis delta.
- **Strategic Oncology Expansion**: Building a robust oncology pipeline using its antibody and PRO-XTEN® platforms, with a focus on indications with high unmet need.
- **Pipeline Acceleration**: Leveraging its platforms to rapidly identify, optimize, and advance candidates from concept to clinic.
- **Building for the Long Term**: The company is strategically building its capabilities and team to become a multi-product, multi-indication biotech.

## Why Work Here
- **Mission-Driven**: Employees are directly contributing to developing transformative medicines for patients with serious diseases.
- **World-Class Team**: Opportunity to work alongside industry-leading scientists, clinicians, and business leaders in the U.S. and Europe.
- **Commitment to Fair Pay**: The company has an "unwavering commitment to fair pay" with a rigorous, proactive approach to compensation based on skills and experience. U.S. salary ranges are shared internally for transparency.
- **Generous Benefits**: Includes health benefits and wellness program, unaccrued time off with structured holidays, on-site paid parking, lunch, and transit spending account (in the U.S.).
- **Workplace Culture**: The company emphasizes "Virtues" over values and a culture of urgency and impact.
- **Locations**: Primarily San Francisco, CA, with some remote options for specific roles (e.g., Regulatory Writer). European offices are also part of the company.

## Sources
1. [vir.bio](https://www.vir.bio/)
2. [vir.bio/careers](https://www.vir.bio/careers/)
3. [job-boards.greenhouse.io/virbiotechnologyinc](http://job-boards.greenhouse.io/virbiotechnologyinc)
4. [vir.bio/about/strategy](https://www.vir.bio/about/strategy/)

## Other roles at Vir Biotechnology

- [Senior Director, Head of Clinical Pharmacology](https://feeny.ai/job/senior-director-head-of-clinical-pharmacology-vir-biotechnology-united-states-3rhq3yhvnnf1) — United States
- [Director, Clinical Contracts](https://feeny.ai/job/director-clinical-contracts-vir-biotechnology-san-francisco-ann0130xxcqz) — San Francisco, CA
- [Senior Director, Total Rewards and HRIS](https://feeny.ai/job/senior-director-total-rewards-and-hris-vir-biotechnology-san-francisco-cbww9w8dee7n) — San Francisco, CA
- [Senior Director, Clinical Research-Program Executive-Oncology](https://feeny.ai/job/senior-director-clinical-research-program-executive-oncology-vir-biotechnology-r41tr7w00x99) — San Francisco, CA
- [Director, Clinical Operations](https://feeny.ai/job/director-clinical-operations-vir-biotechnology-san-francisco-ajxvfttp1cq5) — San Francisco, CA
- [Associate Director, Clinical Scientist](https://feeny.ai/job/associate-director-clinical-scientist-vir-biotechnology-san-francisco-kz6ttfjzvf2m) — San Francisco, CA
- [Associate Director, CMC Project Management](https://feeny.ai/job/associate-director-cmc-project-management-vir-biotechnology-san-francisco-rgwkehm4691f) — San Francisco, CA
- [Associate Director, Quality Systems (Temporary)](https://feeny.ai/job/associate-director-quality-systems-temporary-vir-biotechnology-san-francisco-x0xjcec1q94g) — San Francisco, CA
- [Senior Specialist, QA Operations (Temporary)](https://feeny.ai/job/senior-specialist-qa-operations-temporary-vir-biotechnology-san-francisco-mjvvaa0hjtne) — San Francisco, CA
- [Senior Scientist I, Drug Product & Device Development (Temporary)](https://feeny.ai/job/senior-scientist-i-drug-product-device-development-temporary-vir-biotechnology-yxcegjgez7qk) — San Francisco, CA